Ther­a­pix Bio in the hunt for $12M mi­cro IPO; Prog­en­ics bags $50M loan; Juno is­n't go­ing any­where, for now

A low pro­file Is­raeli biotech named Ther­a­pix Bio­sciences is tak­ing a fli­er on a mi­cro IPO on NAS­DAQ. The biotech has done some pre­clin­i­cal work …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.